Linden Advisors’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding HLGN.WS
LP
HCM
PFM
CCP
SM
CCA
FPA
AC
Linden Advisors's HLGN.WS Position: Q1 2022 in Review
Linden Advisors sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q1 2022, closing a stake of 250,000 shares — an estimated $429K sold.
Linden Advisors first reported a position in HLGN.WS in Q4 2021 and held it in 1 quarter. The position peaked at $429K in Q4 2021. 17 funds tracked by Wall St. Rank hold HLGN.WS as of Q1 2022.
- Linden Advisors reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q1 2022 after selling out during the quarter.
- Linden Advisors sold 250,000 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q1 2022, an estimated $429K.
- Linden Advisors first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 1 quarter.
- Linden Advisors's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $429K in Q4 2021.
- 17 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q1 2022.
Based on Linden Advisors's 13F filing for Q1 2022, filed 16 May 2022.